- Home
- Publications
- Publication Search
- Publication Details
Title
Challenges in HIV Vaccine Research for Treatment and Prevention
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 5, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-09-08
DOI
10.3389/fimmu.2014.00417
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers
- (2014) Claudia Blattner et al. IMMUNITY
- Long-Term Antiretroviral Treatment Initiated at Primary HIV-1 Infection Affects the Size, Composition, and Decay Kinetics of the Reservoir of HIV-1-Infected CD4 T Cells
- (2014) M. J. Buzon et al. JOURNAL OF VIROLOGY
- Silver bullets, glass beads, and strengthening Africa's HIV response
- (2014) Suzanne Leclerc-Madlala LANCET
- Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial
- (2014) Richard B Pollard et al. LANCET INFECTIOUS DISEASES
- Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study
- (2014) Glenda E Gray et al. LANCET INFECTIOUS DISEASES
- Phambili: moving forward without the blindfold
- (2014) Nelson L Michael et al. LANCET INFECTIOUS DISEASES
- Vaccines that stimulate T cell immunity to HIV-1: the next step
- (2014) Andrew J McMichael et al. NATURE IMMUNOLOGY
- Engineering Cellular Resistance to HIV
- (2014) Mark A. Kay et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
- (2014) Pablo Tebas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection
- (2014) Lin Ye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIV-1 Vif N-terminal Motif is required for recruitment of Cul5 to Suppress APOBEC3
- (2014) Sean L Evans et al. Retrovirology
- HIV Vaccines: A Brief Overview
- (2014) D. Lema et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Immune Activation with HIV Vaccines
- (2014) A. S. Fauci et al. SCIENCE
- Therapeutic HIV vaccines: Prior setbacks, current advances, and future prospects
- (2014) Kevin Fisher et al. VACCINE
- Gene Therapy Targeting HIV Entry
- (2014) Chuka Didigu et al. Viruses-Basel
- Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection
- (2013) C. A. Didigu et al. BLOOD
- Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys
- (2013) Dan H. Barouch et al. CELL
- Safety, Tolerability, and Immunogenicity of Repeated Doses of DermaVir, a Candidate Therapeutic HIV Vaccine, in HIV-Infected Patients Receiving Combination Antiretroviral Therapy
- (2013) Benigno Rodriguez et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Viral Persistence in HIV Infection: Much Known, Much to Learn
- (2013) Tae-Wook Chun et al. JOURNAL OF INFECTIOUS DISEASES
- Novel Biopanning Strategy To Identify Epitopes Associated with Vaccine Protection
- (2013) B. C. Bachler et al. JOURNAL OF VIROLOGY
- Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
- (2013) Christine Katlama et al. LANCET
- Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis
- (2013) Sylvie Boyer et al. LANCET INFECTIOUS DISEASES
- Immune clearance of highly pathogenic SIV infection
- (2013) Scott G. Hansen et al. NATURE
- Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
- (2013) Scott M. Hammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein
- (2013) T. P. Johnson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
- (2013) G. D. Tomaras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytomegalovirus Vectors Violate CD8+ T Cell Epitope Recognition Paradigms
- (2013) S. G. Hansen et al. SCIENCE
- Safety, immunogenicity and efficacy assessment of HIV immunotherapy in a multi-centre, double-blind, randomised, Placebo-controlled Phase Ib human trial
- (2013) Marta Boffito et al. VACCINE
- A brief history of the global effort to develop a preventive HIV vaccine
- (2013) José Esparza VACCINE
- Novel Cell and Gene Therapies for HIV
- (2013) J. A. Hoxie et al. Cold Spring Harbor Perspectives in Medicine
- Financing Essential HIV Services: A New Economic Agenda
- (2013) Anna Vassall et al. PLOS MEDICINE
- HIV-1 Vaccine-Induced T-Cell Reponses Cluster in Epitope Hotspots that Differ from Those Induced in Natural Infection with HIV-1
- (2013) Tomer Hertz et al. PLoS Pathogens
- As Good As It Gets? The Problem of HIV Persistence despite Antiretroviral Drugs
- (2012) Alex Sigal et al. Cell Host & Microbe
- Full-Length HIV-1 Immunogens Induce Greater Magnitude and Comparable Breadth of T Lymphocyte Responses to Conserved HIV-1 Regions Compared with Conserved-Region-Only HIV-1 Immunogens in Rhesus Monkeys
- (2012) K. E. Stephenson et al. JOURNAL OF VIROLOGY
- HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies
- (2012) Paolo Monini et al. PLoS One
- HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120
- (2012) James M. Kovacs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU®-Multi-HIVB, in untreated HIV-1 infected subjects
- (2012) Eftyhia Vardas et al. VACCINE
- Therapeutic vaccines against HIV infection
- (2012) Felipe García et al. Human Vaccines & Immunotherapeutics
- Interactions of HIV, Other Sexually Transmitted Diseases, and Genital Tract Inflammation Facilitating Local Pathogen Transmission and Acquisition
- (2011) Kenneth H. Mayer et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Relationship Between Residual Plasma Viremia and the Size of HIV Proviral DNA Reservoirs in Infected Individuals Receiving Effective Antiretroviral Therapy
- (2011) Tae-Wook Chun et al. JOURNAL OF INFECTIOUS DISEASES
- Low-Dose Penile SIVmac251 Exposure of Rhesus Macaques Infected with Adenovirus Type 5 (Ad5) and Then Immunized with a Replication-Defective Ad5-Based SIV gag/pol/nef Vaccine Recapitulates the Results of the Phase IIb Step Trial of a Similar HIV-1 Vaccine
- (2011) H. Qureshi et al. JOURNAL OF VIROLOGY
- Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy
- (2011) Alex Sigal et al. NATURE
- Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
- (2011) Scott G. Hansen et al. NATURE
- Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial
- (2011) Morgane Rolland et al. NATURE MEDICINE
- Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy
- (2010) Steven A Yukl et al. AIDS
- Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
- (2010) Tae-Wook Chun et al. AIDS
- Impact of Viral Dose and Major Histocompatibility Complex Class IB Haplotype on Viral Outcome in Mauritian Cynomolgus Monkeys Vaccinated with Tat upon Challenge with Simian/Human Immunodeficiency Virus SHIV89.6P
- (2010) A. Cafaro et al. JOURNAL OF VIROLOGY
- HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
- (2010) Maria J Buzón et al. NATURE MEDICINE
- Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART
- (2010) Barbara Ensoli et al. PLoS One
- Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton
- (2010) P. U. Cameron et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy
- (2009) Benoît Marin et al. AIDS
- Lentiviral Vector-Based Prime/Boost Vaccination against AIDS: Pilot Study Shows Protection against Simian Immunodeficiency Virus SIVmac251 Challenge in Macaques
- (2009) A.-S. Beignon et al. JOURNAL OF VIROLOGY
- Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies
- (2009) Marie-Claude Boily et al. LANCET INFECTIOUS DISEASES
- Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys
- (2009) Philip R Johnson et al. NATURE MEDICINE
- Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge
- (2009) Scott G Hansen et al. NATURE MEDICINE
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
- (2009) Nicolas Chomont et al. NATURE MEDICINE
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up
- (2009) Olimpia Longo et al. VACCINE
- The preventive phase I trial with the HIV-1 Tat-based vaccine
- (2009) Barbara Ensoli et al. VACCINE
- Containment of Infection in Tat Vaccinated Monkeys After Rechallenge with a Higher Dose of SHIV89.6Pcy243
- (2009) Alessandra Borsetti et al. VIRAL IMMUNOLOGY
- The role of HIV in serious diseases other than AIDS
- (2008) Andrew N Phillips et al. AIDS
- The ‘immunologic advantage’ of HIV-exposed seronegative individuals
- (2008) Masaaki Miyazawa et al. AIDS
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
- (2008) Susan P Buchbinder et al. LANCET
- A vaccine strategy against AIDS: An HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaques
- (2008) V. Vieillard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now